Tags : Multiple Antibody-Drug Conjugates

Biotech

Pfizer Signs a WW License Agreement with Pyxis to Develop

Shots: Pfizer to receive an up front, equity in Pyxis and is eligible for development & commercial milestones as well as royalties on potential sales of ADCs Pyxis gets a WW license to develop and commercialize PYX-201 and PYX-203. Pfizer will continue to support the development and advancement of ADCs portfolio via an equity investment […]Read More